What happened
Smith Nephew plc (NYSE: SNN) said it will announce its third-quarter 2026 trading report on Wednesday 4 November 2026 at 7.00am GMT / 2.00am EST.
A conference call for financial analysts follows at 12.00pm GMT / 7.00am EST. The quarter ended 26 September 2026.
It says the business focuses on repair, regeneration and replacement of soft and hard tissue through Orthopaedics, Sports Medicine ENT and Advanced Wound Management.
Key numbers
| Metric | Latest | Change | Source |
|---|---|---|---|
| 2025 annual sales | $6.2 billion | SEC 6-K | |
| Employees | 17,000 employees | SEC 6-K | |
| Countries of operation | more than 100 countries | SEC 6-K | |
| Third-quarter 2026 trading report | Wednesday 4 November 2026 at 7.00am GMT / 2.00am EST | SEC 6-K | |
| Analyst call | 12.00pm GMT / 7.00am EST | SEC 6-K |
Read more: Smith Nephew (SNN) stock analysis and investment case
Why it matters
OptimistFi's case is that Smith Nephew's stable product mix can turn into predictable cash flow, with mid-single-digit top-line growth and margin improvement doing the work.
This filing does not change that case. It only sets the timing of the next update.
That timing matters because investors now have a fixed point for the next look at a business that said it generated $6.2 billion of annual sales in 2025.
The filing also gives a fuller view of the company. Smith Nephew says it was founded in Hull, UK, in 1856, has 17,000 employees and operates in more than 100 countries.
It says the company focuses on repair, regeneration and replacement of soft and hard tissue through Orthopaedics, Sports Medicine ENT and Advanced Wound Management.
Those details frame the upcoming report as the next check on a broad medical technology business, not just one product line.
The filing makes no operating claims about the quarter. So the investment case stays the same until the report is released.
Investors will still be watching for whether the business is tracking the growth and margin pattern the case depends on.
Browse: stock research on every company OptimistFi covers
What's next
Smith Nephew's third-quarter 2026 trading report is scheduled for Wednesday 4 November 2026 at 7.00am GMT / 2.00am EST.
The analyst call follows at 12.00pm GMT / 7.00am EST. A report showing steady growth and margin improvement would strengthen OptimistFi's case.
A softer read would weaken it.
More from OptimistFi
- SNN stock: the Smith Nephew thesis, its status and the next test to watch
- Richardson Electronics, Ltd. (NASDAQ: RELL) Margin Gains Need Context
- Arqit Quantum Inc. (NASDAQ: ARQQ) Nearly Doubles Revenue
- Profound Medical Corp. (NASDAQ: PROF) Revenue Nearly Doubles
- Stock research on every company OptimistFi covers
- Latest stock research and investment-case updates
- OptimistFi: evidence-first equity research
Sources
- SEC 6-K — Notice of results dated October 08, 2026
Read the full OptimistFi thesis on Smith Nephew plc: https://optimistfi.com/stocks/SNN
See what would break the Smith Nephew plc thesis and track it live on the OptimistFi Thesis-Break Engine.
Browse every company OptimistFi covers at optimistfi.com/stocks, or read the latest evidence-first research.
The full Smith Nephew plc investment case, its status and the next test to watch live on the Smith Nephew plc thesis page.
Originally published on OptimistFi, evidence-first equity research. More at optimistfi.com.
